Clopimozide

Clopimozide
Clinical data
ATC code	none;
Identifiers
	IUPAC name 3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-6-chloro-1H-benzimidazol-2-one;
CAS Number	53179-12-7;
PubChem CID	65449;
ChemSpider	58909;
UNII	7C6TA32SD2;
KEGG	D02649;
ChEMBL	ChEMBL2104161;
CompTox Dashboard (EPA)	DTXSID60201238 ;
Chemical and physical data
Formula	C28H28ClF2N3O
Molar mass	496.00 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Fc1ccc(cc1)C(c2ccc(F)cc2)CCCN5CCC(N4c3ccc(Cl)cc3NC4=O)CC5;
	InChI InChI=1S/C28H28ClF2N3O/c29-21-7-12-27-26(18-21)32-28(35)34(27)24-13-16-33(17-14-24)15-1-2-25(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24-25H,1-2,13-17H2,(H,32,35); Key:JCZYXTVBWHAWLL-UHFFFAOYSA-N;

Clopimozide (R-29,764) is a typical antipsychotic drug of the diphenylbutylpiperidine class. It is very potent and has an extremely long duration of action, lasting at least one week with a single dose. It was developed by Janssen Pharmaceutica but was never marketed.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.